FIELD: biotechnology.
SUBSTANCE: strain DSM 32186 of Faecalibacterium prausnitzii and strain DSM 32187 of Desulfovibrio piger are proposed for use as a probiotic. The strains show a synergistic effect with increased production of butyrate.
EFFECT: invention can be used in the treatment or prevention of a disease associated with reduced levels of butyrate.
2 cl, 5 dwg, 4 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FAECALIBACTERIUM PRAUSNITZII AND DESULFOVIBRIO PIGER FOR USE IN TREATMENT OR PREVENTION OF DIABETES AND INTESTINAL DISEASES | 2016 |
|
RU2754367C2 |
| USE OF MICROBIAL COMMUNITIES FOR THE TREATMENT OF HUMANS AND ANIMALS | 2017 |
|
RU2758387C2 |
| USE OF MICROBIAL COMMUNITIES FOR TREATING HUMANS AND ANIMALS | 2017 |
|
RU2823233C2 |
| COMPOSITIONS AND METHODS FOR INCREASING OR MAINTAINING ABUNDANCE OF FAECALIBACTERIUM PRAUSNITZII | 2015 |
|
RU2712568C2 |
| METHOD FOR DIFFERENTIATED SELECTION OF THERAPY FOR PATIENTS WITH ULCERATIVE COLITIS ON BACKGROUND OF TYPE 2 DIABETES MELLITUS | 2024 |
|
RU2821023C1 |
| ADAPTATION METHOD | 2016 |
|
RU2778569C2 |
| METHODS FOR IMPROVING BLOCKADE THERAPY OF IMMUNE CHECKPOINTS THROUGH MICROBIOME MODULATION | 2017 |
|
RU2793582C2 |
| SYNBIOTIC COMPOSITIONS | 2019 |
|
RU2799354C2 |
| TREATMENT OF INTRAHEPATIC CHOLESTASIS AND RELATED LIVER DISEASES | 2016 |
|
RU2743405C2 |
| USE OF CAROTENOID OF MICROBIAL ORIGIN THAT AFFECTS COMPOSITION OF INTESTINAL MICROORGANISMS | 2017 |
|
RU2759600C2 |
